The timing could not be more significant. According to the National Mental Health Survey 2015–16, conducted by NIMHANS across ...
A groundbreaking clinical trial was recently presented at the Alzheimer's Association International Conference (AAIC) on the ...
In a first-of-its-kind clinical trial, U.S. researchers have found that people with agitation and dementia in late life who ...
A new meta-analysis suggests that CBD may improve emotional behavior and cognition in animal models, but researchers caution ...
Nearly 90% of trial participants improved with treatment ...
The second phase of LiBBY Trial has indicated that cannabis-driven treatment could help alleviate symptoms of agitation in ...
Leiutis Pharma gets CDSCO nod for global-first synthetic CBD therapy for mild to moderate anxiety disorders: Our Bureau, Bengaluru Tuesday, July 14, 2026, 16:25 Hrs [IST] Leiutis ...
For years, Alzheimer’s-related agitation had just one FDA-approved treatment, an antipsychotic. This spring, a ...
Agitation is a common and tough-to-control symptom of late-stage dementia. But a new trial suggests that a combination of two ...
A new study has found cannabidiol (medicinal cannabis) to be a promising treatment for several drug-resistant forms of ...
A new study reveals a purified medical THC/CBD oil formulation drastically reduces severe agitation in late-stage dementia.